UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Novel Ribosomal Mutations in Staphylococcus aureus Strains Identified through Selection with the Oxazolidinones Linezolid and Torezolid (TR-700)

Antimicrobial Agents and Chemotherapy, 2009-12, Vol.53 (12), p.5265-5274

2009

Volltextzugriff (PDF)

Tedizolid for the Management of Human Infections: In Vitro Characteristics

Clinical infectious diseases, 2014-01, Vol.58 (suppl_1), p.S35-S42

2014

Volltextzugriff (PDF)

Mutations in Ribosomal Protein L3 Are Associated with Oxazolidinone Resistance in Staphylococci of Clinical Origin

Antimicrobial Agents and Chemotherapy, 2009-12, Vol.53 (12), p.5275-5278

2009

Volltextzugriff (PDF)

Anthracimycin, a Potent Anthrax Antibiotic from a Marine-Derived Actinomycete

Angewandte Chemie International Edition, 2013-07, Vol.52 (30), p.7822-7824

International ed. in English, 2013

Volltextzugriff (PDF)

Absorption, distribution, metabolism, and excretion of the novel antibacterial prodrug tedizolid phosphate

Drug metabolism and disposition, 2014-08, Vol.42 (8), p.1275-1284

2014

Volltextzugriff (PDF)

Structure-Activity Relationships of Diverse Oxazolidinones for Linezolid-Resistant Staphylococcus aureus Strains Possessing the cfr Methyltransferase Gene or Ribosomal Mutations

Antimicrobial Agents and Chemotherapy, 2010-12, Vol.54 (12), p.5337-5343

2010

Volltextzugriff (PDF)

Results of the Surveillance of Tedizolid Activity and Resistance Program: in vitro susceptibility of Gram-positive pathogens collected in 2011 and 2012 from the United States and Europe

Diagnostic microbiology and infectious disease, 2015-02, Vol.81 (2), p.112-118

2015

Volltextzugriff (PDF)

Genetic Environment and Stability of cfr in Methicillin-Resistant Staphylococcus aureus CM05

Antimicrobial Agents and Chemotherapy, 2012-01, Vol.56 (1), p.332-340

2012

Volltextzugriff (PDF)

Low Fitness Cost of the Multidrug Resistance Gene cfr

Antimicrobial Agents and Chemotherapy, 2011-08, Vol.55 (8), p.3714-3719

2011

Volltextzugriff (PDF)

Elevated Linezolid Resistance in Clinical cfr-Positive Staphylococcus aureus Isolates Is Associated with Co-Occurring Mutations in Ribosomal Protein L3

Antimicrobial Agents and Chemotherapy, 2010-12, Vol.54 (12), p.5352-5355

2010

Volltextzugriff (PDF)

The IL-8 protease SpyCEP/ScpC of group A Streptococcus promotes resistance to neutrophil killing

Cell host & microbe, 2008-08, Vol.4 (2), p.170-178

2008

Volltextzugriff (PDF)

Comparison of In Vitro Killing Activity of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four Candida auris Clades in RPMI-1640 in the Absence and Presence of Human Serum

Microorganisms (Basel), 2021-04, Vol.9 (4), p.863

2021

Volltextzugriff (PDF)

Rezafungin (CD101) demonstrates potent in vitro activity against Aspergillus, including azole-resistant Aspergillus fumigatus isolates and cryptic species

Journal of antimicrobial chemotherapy, 2018-11, Vol.73 (11), p.3063-3067

2018

Volltextzugriff (PDF)

Streptococcus iniae M-like protein contributes to virulence in fish and is a target for live attenuated vaccine development

PloS one, 2008-07, Vol.3 (7), p.e2824-e2824

2008

Volltextzugriff (PDF)

Time-Kill Kinetics of Rezafungin (CD101) in Vagina-Simulative Medium for Fluconazole-Susceptible and Fluconazole-Resistant Candida albicans and Non-albicans Candida Species

Infectious diseases in obstetrics and gynecology, 2018, Vol.2018 (2018), p.1-10

2018

Volltextzugriff (PDF)

In Vivo Efficacy of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four Candida auris Clades in a Neutropenic Mouse Bloodstream Infection Model

Journal of fungi (Basel), 2024-08, Vol.10 (9), p.617

2024

Volltextzugriff (PDF)

Relative Frequency of Paradoxical Growth and Trailing Effect with Caspofungin, Micafungin, Anidulafungin, and the Novel Echinocandin Rezafungin against Candida Species

Journal of fungi (Basel), 2020-08, Vol.6 (3), p.136

2020

Volltextzugriff (PDF)

In vitro activity of rezafungin against common and rare Candida species and Saccharomyces cerevisiae

Journal of antimicrobial chemotherapy, 2019-12, Vol.74 (12), p.3505-3510

2019

Volltextzugriff (PDF)

Multicentre validation of a modified EUCAST MIC testing method and development of associated epidemiologic cut-off (ECOFF) values for rezafungin

Journal of antimicrobial chemotherapy, 2023-01, Vol.78 (1), p.185-195

2023

Volltextzugriff (PDF)

Characterization of In Vitro Resistance Development to the Novel Echinocandin CD101 in Candida Species

Antimicrobial agents and chemotherapy, 2016-10, Vol.60 (10), p.6100-6107

2016

Volltextzugriff (PDF)

Streptococcus iniae Capsule Impairs Phagocytic Clearance and Contributes to Virulence in Fish

Journal of Bacteriology, 2007-02, Vol.189 (4), p.1279-1287

2007

Volltextzugriff (PDF)

Development and preliminary validation of a modified EUCAST yeast broth microdilution MIC method with Tween 20-supplemented medium for rezafungin

Journal of antimicrobial chemotherapy, 2023-04, Vol.78 (4), p.1102-1110

2023

Volltextzugriff (PDF)

CD101: a novel long‐acting echinocandin

Cellular microbiology, 2016-09, Vol.18 (9), p.1308-1316

2016

Volltextzugriff (PDF)

Outcomes by Candida spp. in the ReSTORE Phase 3 trial of rezafungin versus caspofungin for candidemia and/or invasive candidiasis

Antimicrobial agents and chemotherapy, 2024-05, Vol.68 (5), p.e0158423

2024

Volltextzugriff (PDF)

In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis

Journal of antimicrobial chemotherapy, 2017-05, Vol.72 (5), p.1355-1358

2017

Volltextzugriff (PDF)

1 – 25 von 138

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(125)
Mit Volltextzugriff
(109)

Publikationsform

Sprache

Englisch
(136)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Novel Ribosomal Mutations in Staphylococcus aureus Strains Identified through Selection with the Oxazolidinones Linezolid and Torezolid (TR-700)

Tedizolid for the Management of Human Infections: In Vitro Characteristics

Mutations in Ribosomal Protein L3 Are Associated with Oxazolidinone Resistance in Staphylococci of Clinical Origin

Anthracimycin, a Potent Anthrax Antibiotic from a Marine-Derived Actinomycete

Absorption, distribution, metabolism, and excretion of the novel antibacterial prodrug tedizolid phosphate

Structure-Activity Relationships of Diverse Oxazolidinones for Linezolid-Resistant Staphylococcus aureus Strains Possessing the cfr Methyltransferase Gene or Ribosomal Mutations

Results of the Surveillance of Tedizolid Activity and Resistance Program: in vitro susceptibility of Gram-positive pathogens collected in 2011 and 2012 from the United States and Europe

Genetic Environment and Stability of cfr in Methicillin-Resistant Staphylococcus aureus CM05

Low Fitness Cost of the Multidrug Resistance Gene cfr

Elevated Linezolid Resistance in Clinical cfr-Positive Staphylococcus aureus Isolates Is Associated with Co-Occurring Mutations in Ribosomal Protein L3

The IL-8 protease SpyCEP/ScpC of group A Streptococcus promotes resistance to neutrophil killing

Comparison of In Vitro Killing Activity of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four Candida auris Clades in RPMI-1640 in the Absence and Presence of Human Serum

Rezafungin (CD101) demonstrates potent in vitro activity against Aspergillus, including azole-resistant Aspergillus fumigatus isolates and cryptic species

Streptococcus iniae M-like protein contributes to virulence in fish and is a target for live attenuated vaccine development

Time-Kill Kinetics of Rezafungin (CD101) in Vagina-Simulative Medium for Fluconazole-Susceptible and Fluconazole-Resistant Candida albicans and Non-albicans Candida Species

In Vivo Efficacy of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four Candida auris Clades in a Neutropenic Mouse Bloodstream Infection Model

Relative Frequency of Paradoxical Growth and Trailing Effect with Caspofungin, Micafungin, Anidulafungin, and the Novel Echinocandin Rezafungin against Candida Species

In vitro activity of rezafungin against common and rare Candida species and Saccharomyces cerevisiae

Multicentre validation of a modified EUCAST MIC testing method and development of associated epidemiologic cut-off (ECOFF) values for rezafungin

Characterization of In Vitro Resistance Development to the Novel Echinocandin CD101 in Candida Species

Streptococcus iniae Capsule Impairs Phagocytic Clearance and Contributes to Virulence in Fish

Development and preliminary validation of a modified EUCAST yeast broth microdilution MIC method with Tween 20-supplemented medium for rezafungin

CD101: a novel long‐acting echinocandin

Outcomes by Candida spp. in the ReSTORE Phase 3 trial of rezafungin versus caspofungin for candidemia and/or invasive candidiasis

In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis

Suchergebnisse filtern